Brainstorm Cell Therapeutics reported $19.26M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Adamis Pharmaceuticals ADMP:US 27.79M 7.41M
Biogen BIIB:US $ 7915.9M 59.4M
Brainstorm Cell Therapeutics BCLI:US $ 19.26M 4.02M
Cerulean Pharma CERU:US $ 47.82M 7.48M
Cytokinetics CYTK:US $ 623.53M 87.85M
Gilead Sciences GILD:US $ 12629M 2143M
Halozyme Therapeutics HALO:US $ 988.69M 62.4M
Idera Pharmaceuticals IDRA:US $ 29.36M 4.68M